denkapparat Operations GmbH Invests $1.07 Million in Corteva, Inc. $CTVA

denkapparat Operations GmbH acquired a new position in Corteva, Inc. (NYSE:CTVA) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 12,698 shares of the company’s stock, valued at approximately $1,075,000.

Several other institutional investors have also added to or reduced their stakes in CTVA. EFG International AG bought a new stake in shares of Corteva in the 2nd quarter valued at $25,000. Compass Financial Management LLC bought a new position in Corteva during the second quarter worth $25,000. JPL Wealth Management LLC acquired a new position in Corteva in the third quarter valued at $25,000. Garton & Associates Financial Advisors LLC acquired a new position in Corteva in the fourth quarter valued at $27,000. Finally, Bank of Jackson Hole Trust bought a new stake in Corteva during the fourth quarter valued at $28,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Price Performance

Shares of NYSE CTVA opened at $88.71 on Friday. The firm has a market capitalization of $59.19 billion, a P/E ratio of 58.75, a P/E/G ratio of 2.76 and a beta of 0.57. The firm’s 50-day moving average price is $83.31 and its 200-day moving average price is $80.96. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same period last year, the business posted $2.20 EPS. The firm’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is 47.68%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Citigroup increased their price target on Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Morgan Stanley raised their target price on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Finally, JPMorgan Chase & Co. boosted their price target on Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.